Leukemia, Erythroblastic, Acute
"Leukemia, Erythroblastic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Descriptor ID |
D004915
|
| MeSH Number(s) |
C04.557.337.539.275.325 C15.378.190.636.276
|
| Concept/Terms |
Leukemia, Erythroblastic, Acute- Leukemia, Erythroblastic, Acute
- Myeloid Leukemia, Acute, M6
- Erythroleukemia
- Erythroleukemias
- Di Guglielmo's Disease
- Di Guglielmos Disease
- Disease, Di Guglielmo's
- Erythremic Myelosis
- Erythremic Myeloses
- Myeloses, Erythremic
- Myelosis, Erythremic
- Erythroblastic Leukemia, Acute
- Acute Erythroblastic Leukemia
- Acute Erythroblastic Leukemias
- Erythroblastic Leukemias, Acute
- Leukemia, Acute Erythroblastic
- Leukemias, Acute Erythroblastic
- Leukemia, Myeloid, Acute, M6
- Di Guglielmo Disease
- Disease, Di Guglielmo
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Erythroblastic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Erythroblastic, Acute".
This graph shows the total number of publications written about "Leukemia, Erythroblastic, Acute" by people in this website by year, and whether "Leukemia, Erythroblastic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 2 | 1 | 3 |
| 1996 | 1 | 4 | 5 |
| 1998 | 1 | 4 | 5 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 2 | 3 |
| 2009 | 3 | 0 | 3 |
| 2010 | 4 | 0 | 4 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 5 | 0 | 5 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Erythroblastic, Acute" by people in Profiles.
-
Immature erythroblasts in pleural effusion: an initial presentation of acute erythroid leukemia in a patient with a history of MDS. Blood. 2024 08 15; 144(7):794.
-
GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues. Am J Clin Pathol. 2022 08 04; 158(2):228-234.
-
Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy. Leuk Res. 2022 07; 118:106860.
-
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice. Leukemia. 2021 07; 35(7):1949-1963.
-
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions. MAbs. 2019 04; 11(3):593-605.
-
A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 06; 31(6):873-880.
-
"Hof" in pronormoblasts: pure erythroid leukemia mimicking plasma cell myeloma. Blood. 2017 09 28; 130(13):1600.
-
Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev. 2018 03; 32(2):96-105.
-
Response to Dr. Bain's comment on our review article: Pure Erythroid Leukemia. Am J Hematol. 2017 10; 92(10):E622.
-
More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood. 2017 05 04; 129(18):2584-2587.